Home

ACCESS
Resources

  1. Pilot Funding
  2. AEGIS Influenza
  3. Atlas
  4. Community Research - CBPR
  5. Core Facilities
  6. HarvardTrials
  7. In/Outpatient Resources
  8. Law and Health Policy
  9. Medications and Society
  10. Pathology Specimen Locator
  11. SHRINE
  12. Translational Technologies
  13. Webdash
  14. Consultation Programs
  15. Biostatistical Consulting
  16. Genetics Consulting
  17. Imaging Consulting
  18. Provider and Health Systems Research
  1. Pilot Grant Funding Pilot Grants address important problems in human clinical and/or translational research and require interdisciplinary or cross-institutional collaboration.
  2. AEGIS AEGIS Influenza provides a population-level view of regional influenza activity, demonstrating current spatial and temporal patterns and comparing them with historical data. AEGIS Influenza bridges the clinical and public health environments, providing clinical data to inform public health decisions as well as epidemiological context to inform clinical decisions.
  3. Atlas View the maps, driving directions, phone numbers, and shuttle schedules for all the Harvard Catalyst institutions in a single place. No more hunting around for this vital information.
  4. Community-Based Participatory Research Community-Based Participatory Research (CBPR) is an emerging orientation to research which involves scientific inquiry that equitably involves both community stakeholders and investigators at all levels of the research process from design to dissemination. CBPR involves a partnership between the community and the investigator(s) where each group shares equal ownership of the process and products of research collaboration.
  5. Core Facilities Search and browse this inventory of core facilities at Harvard and Harvard-affiliated academic healthcare institutions. This listing will grow, as more core facilities become available to Harvard Catalyst investigators.
  6. HarvardTrials HarvardTrials is the Harvard view of ClinicalTrials.gov. ClinicalTrials.gov, provided by the U.S. National Institutes of Health, is a registry of federally and privately supported clinical trials conducted in the United States and around the world. HarvardTrials allows you to search and browse just those clinical trials that are being conducted at Harvard and its affiliated institutions.
  7. In/Outpatient Resources The Harvard Catalyst Participant and Clinical Interaction Resources (PCIR) program allows investigators to perform cutting-edge human research and facilitates human interdisciplinary research across the broad spectrum of departments and research areas through transformation and extension of the former NIH-funded General Clinical Research Centers.
  8. Law and Health Policy The Petrie-Flom Center at Harvard Law School is dedicated to interdisciplinary research and debate of cutting-edge issues in health law policy, biotechnology, and bioethics.
  9. Medications and Society The Harvard Interfaculty Initiative on Medications and Society is a collaborative effort to bring together faculty and students across all Departments and Schools of Harvard University who share an interest in how prescription drugs are developed, approved, regulated, and paid for; as well as how they are prescribed, viewed, and taken by patients.
  10. Pathology Specimen Locator The Pathology Specimen Locator (PSL) is a distributed database indexing millions of discarded human specimens that can be used for translational studies such as biomarker discovery and validation. Investigators use PSL to locate paraffin and frozen specimens available across the Harvard pathology departments. When specimens matching the study criteria are located, investigators can request tissue and pathology services.
  11. SHRINE SHRINE, or Shared Health Research Information Network, is a peer-to-peer network of clinical databases that is being developed and will launch in the second quarter of 2009. An authorized investigator can use the Query Aggregation Interface to simultaneously send queries to multiple health care centers, without the need for a Harvard Catalyst-wide central data warehouse.
  12. Laboratory Translation Technology The Harvard Catalyst - Laboratory for Innovative Translational Technologies (HC-LITT) provides Harvard's basic and clinical research community with early access to enabling, leading-edge technologies. HC-LITT's 'collaborative research model' brings together a myriad of innovative technologies in one place, putting them in the hands of biomedical investigators from diverse disciplines.
  13. WebDash Webdash is a tool that enables you to instantly share any web page with anyone in your address book. For example, with Webdash you can annotate published papers on the web, share that with your colleagues, and start a discussion.
  14. Biostatistics Drawing on a team of highly skilled biostatisticians from the Harvard academic and hospital community, the Biostatistics Consultation Program offers free statistical consultations to researchers as they launch new clinical translation projects.
  15. Genetics The Harvard Catalyst Translational Genetics Service offers expert consultations in genetics research to all members of the institutions that comprise the Harvard Clinical and Translational Science community. These consults will aid translational investigators in the design and implementation of genetic studies.
  16. Imaging Consultation The Harvard Catalyst Medical Imaging Service offers free consultations to investigators as they launch new translational imaging research projects. Informed by the diverse expertise of imaging leaders from the Harvard academic and hospital community, these consults will aid translational investigators in the design and implementation of imaging studies.
  17. Provider and Health Systems Research The Harvard Catalyst Provider & Health Systems Research Program helps investigators plan and conduct research based on collaborations with a) Massachusetts-based health plans (including access to defined populations and data resources); and b) community practice settings (including practice-based research networks and Harvard-affiliated health care delivery systems).
People News

  1. A workshop on pharmacogenetics research in large populations



    | Full story

  2. Interdisciplinary meeting creates opportunities for expanded collaborations in diabetes research



    | Full story

  3. Join a forum on community-based participatory research resources and opportunities



    | Full story

  4. Grant writing is about to get easier, with your help.



    | Full story

  5. Harvard research community responds enthusiastically to the latest Pilot Grant RFA



    | Full story

  6. Help shape the future direction of health disparities research at Harvard



    | Full story

More ...
coming soon

New Laboratory Accelerates Research into the Clinical Setting

The Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT) will put a myriad of innovative technologies in the hands of clinical and translational researchers. Temporarily, it will be located in New Research Building-3rd floor but will relocate to its permanent home, the Harvard Institutes of Medicine, in July, 2009. The lab will be a one-stop resource center featuring the newest and most powerful industry and Harvard community technologies. It will also be a forum for bringing together a potent mix of biomedical researchers, clinicians, bioinformaticians, physical scientists, and engineers using integrated, interdisciplinary approaches in solving challenging clinical problems.

To assist translational researchers, the HC-LITT will focus on:

  • New Technology: providing investigators with access to diverse translational technologies ranging from sample preparation to measuring protein-small molecule interactions;

  • Interdisciplinary Collaboration: providing an open environment for brainstorming new approaches to tackling problems that can only be solved with new technologies;

  • Analytical Consulting: providing computational guidance related to the novel technologies in conjunction with the Harvard Catalyst Biostatistical Consulting Program.

HC-LITT will also engage in specific projects that adapt/modify new assays/technologies with the aim that they are able to become core technologies: user friendly, cheap, and clinically robust. HC-LITT will strive to develop these technologies so that other programs can offer these services to the translational community at large.

The HC-LITT will be fully open for investigator use by July, 2009.

Contact Winston Patrick Kuo, Director of Harvard Catalyst Laboratory for Innovative Translational Technologies for more information.